Innoviva (INVA) Stock
Innoviva (INVA) closed at $19.03 on Nov 13, 2026; its Tenet Score is 74 of 100 against 409 Healthcare peers.
7 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $19.03
- Nov 13, 2026
- Market cap
- $1.4B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 7.1×
- price ÷ earnings
- 52-week range
- 18.66 – 25.14
- low → high
- Tenet Score
- 74/100
- Solid · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Innoviva Inc scores 74/100. Solid. Strongest on value and financial health, trading at 7× earnings versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✓ Buffett Quality
- ✕ Piotroski F-Score
- ~ Munger Compounders
- ~ Magic Formula
- ~ Graham Defensive
- ✓ Lynch GARP
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled cortic…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Korsana Biosciences Inc.KRSA | 41 | $1.4B |
| Novavax, Inc.NVAX | 58 | $1.4B |
| AnaptysBio IncANAB | 50 | $1.4B |
| Ocular Therapeutix IncOCUL | 53 | $1.4B |
| Intellia Therapeutics IncNTLA | 43 | $1.4B |
| Mineralys Therapeutics IncMLYS | 55 | $1.4B |
| Taysha Gene Therapies IncTSHA | 59 | $1.3B |
| Mannkind CorpMNKD | 39 | $1.3B |
| AlvotechALVO | 44 | $1.3B |
| UroGen Pharma LtdURGN | 44 | $1.3B |
Common questions
What sector and industry is Innoviva in?
Innoviva is in the Healthcare sector and the Drugs industry.
What is Innoviva's Tenet Score?
Innoviva's Tenet Score is 74 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




